Table 4.
Any ERCP‐related adverse event, n (%) | 45 (3.3) |
Specific ERCP‐related adverse event, n (%) | |
Cholangitis ‡ | 33 (2.4) |
Abdominal pain | 7 (0.5) |
Post‐ERCP pancreatitis | 5 (0.4) |
Bleeding | 3 (0.2) |
Perforation | 0 (0) |
ERCP, endoscopic retrograde cholangiopancreatography.
A total of 1369 ERCP procedures were carried out over the study period.
Two out of the 33 cases of cholangitis occurred secondary to stent migration.